Avid Bioservices (NASDAQ:CDMO) reported its Q3 earnings results on Tuesday, March 8, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Avid Bioservices reported in-line EPS of $0.04 versus an estimate of $0.04.
Revenue was up $9.70 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.04 which was followed by a 1.33% drop in the share price the next day.
Here's a look at Avid Bioservices's past performance:
| Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.02 | 0.04 | -0.03 | |
| EPS Actual | 0.06 | 0.10 | -0.04 | 0.01 |
| Revenue Estimate | 24.02M | 27.81M | 21.60M | 19.07M |
| Revenue Actual | 26.11M | 30.75M | 27.61M | 21.81M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
